Skip to content

The Effect Of Interpersonal Psychotherapy On Quality Of Life Among Breast Cancer Patients With Common Mental Disorder: A Randomized Control Trial at Tikur Anbessa Specialized Hospital.

The Effect Of Interpersonal Psychotherapy On Quality Of Life Among Breast Cancer Patients With Common Mental Disorder: A Randomized Control Trial at Tikur Anbessa Specialized Hospital.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202011629348967
Enrollment
114
Registered
2020-11-20
Start date
2019-02-16
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Interventions

Interpersonal Psychotherapy for Ethiopian Use
Standard treatment

Sponsors

Catholic Organization for Relief and Development AID school of public health female cancer initiative.
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Participants were included when Breast Cancer patients were 1) aged 18 years and above 2)those who are diagnosed with anxiety and depression using HADS (HADS>=8) at Tikur Anbessa Specialized Teaching Hospital oncology center, Addis Ababa, Ethiopia.

Exclusion criteria

Exclusion criteria: Participants were excluded from the study when they were on 1) severe physical illness 2) severe mental illness (psychosis & mania), 3) functionally impairing substance abuse, 3) and Patients who are acutely suicidal were excluded from the study.

Design outcomes

Primary

MeasureTime frame
Primary outcome The primary outcomes were level of depression and anxiety. It was measured using Ethiopian validated Hospital Anxiety and Depression measurement scale (HADS) which showed good consistency between the items and high test-retest reliability. HADS is a widely used health-related quality of life instrument for measuring psychological distress in non-psychiatric patients. The items are rated on a four-point Likert scale ranging from 0 to 3 giving maximum and minimum scores of 0 and 21 respectively for each subscale. Sub-scores on the anxiety or depression sub-scales ranging from 0 to 7 are considered normal; while 8 to 10 and 11 to 21 are considered to cause for concern’ and ‘probable cases of anxiety or depression’ respectively. The interpretation of HADS measurement scale is as follows:- •0 to 7--- normal •8 to 10----- mild •11 to 14 ----- moderate and •15 to 21----- severe.

Secondary

MeasureTime frame
The secondary outcome of this study was the quality of life. It was assessed using the Amharic version of EORTC QLQ-C30 that is found to be reliable and had an acceptable validity to assess the QOL among cancer patients. The questionnaires have 30 items with three scales and 15 different domains. The three scales used were functional, symptom scale, and general health status as a separate scale. Domains such as physical, role, cognitive, emotional, and social functioning under functional scale whereas dyspnea, pain, fatigue, insomnia, appetite loss, nausea/vomiting, constipation, diarrhea as well as financial difficulties under symptom scale and general health status as a separate scale. The scoring was done according to the Quality of life questionnaire-C30 manual. According to the manual, the quality of life questionnaire version-3 has 30 item questions to assess the quality of life of cancer patients in general. So after the patients' response was taken carefully using questions ranging from Item 1(I1??to Item 30 (I??), the raw score was calculated and further be used for each scales (Functional, symptom and general health status), then linear transformation were undertaken for each domain under the subsequent scales. This raw score was further be used for each scale (Functional, symptom, and general health status), then linear transformation was undertaken for each domain under the subsequent scales. The linear transformation from 0-100 was applied to obtain the score S, the individual score for each domain. The linear transformation was done to use individual scores for the subsequent analysis. The formula written below was used for functional, symptom scale, and general status. Functional scales: S= 1- (RS-1) *100 Range Symptom scales/items: S=???RS -1???range??100 Global health status / QoL: S ????RS -1???range??100 Accordingly, range (R) is the difference between the maximum possible value an

Countries

Ethiopia

Contacts

Public ContactWinini Belay

Department of Reproductive health and Health System Management School of Public Health

wininiquidnac@gmail.com251921388192

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026